Tagged with Africa

Disappointing but Not Surprising: Moderna’s Withdrawal from Manufacturing Vaccines in Kenya
5-in-1 Meningitis Vaccine Launched in Nigeria: One Step Closer to Elimination by 2030?
The African Medicines Agency: Amplifying Impact with a Practical Path Towards Regulatory Maturity
3 Key Takeaways from Europe’s Premier Regulatory Conference
Sania Nishtar Becomes New Gavi CEO with Focus on 2030 Strategy, Vaccine Equity & Fundraising
Drug Shortages in the Global South: A Proposed Parallel Tech and Reg Transfer Framework
HIV/AIDS Treatment Trends and Progress: Where Do We Stand Today?
The Oxford R21 Malaria Vaccine and the Imperative of Continued Malaria Testing
Ayman Cheikh Lahlou – CEO, Cooper Pharma
Anthony Y. Lauw – GM & Head of Human Pharma Northwest Africa, Boehringer Ingelheim
Khalid LAHLOU – General Director, National Health Insurance Agency (ANAM)
Diego Forero – North Africa Cluster Lead, Pfizer
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here